Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
Tuesday, November 20, 2018
Piramal Pharma Solutions announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore, Chennai, India.
read more
Piramal Pharma Solutions announced a $90M investment plan to expand two of its U.S. facilities, which are critical to its integrated offering. This ambitious investment underscores the company's commitment to industry leadership through continuous ...
read more
Piramal Pharma Limited's Pharma Solutions announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
read more
Tuesday, February 08, 2022
Piramal Pharma Limited's Pharma Solutions business announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure at ...
read more
Tuesday, December 03, 2019
Piramal Enterprises Limited's Pharma Solutions business announced a partnership with BerGenBio on the development of bemcentinib for the treatment of elderly patients with relapsed AML.
read more
Piramal Pharma Solutions (PPS) announced the launch of its Xcelerate Integrated Solutions platform.
read more
Piramal Pharma Limited's Pharma Solutions business announced it is providing Theratechnologies with GMP manufacturing of sterile fill/finish drug product.
read more
Thursday, August 21, 2025
Piramal Pharma Solutions and NewAmsterdam Pharma Company announced the opening of a dedicated oral solid dosage (OSD) form suite at Piramal's facility in Sellersville, Pennsylvania, USA. As one of Piramal Pharma Solutions' focused drug product ...
read more
Thursday, October 30, 2025
Piramal Pharma announced its strategic partnership with Korean biotech firm IntoCell to expand its offerings in the rapidly growing antibody-drug conjugate (ADC) and bioconjugate market.
read more
Tuesday, September 16, 2025
Piramal Pharma Solutions announced its acquisition of a Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK.
read more
Tuesday, December 02, 2025
Piramal Pharma Solutions announced the successful completion of its journey to compliance with global requirements for nitrosamine impurities in pharmaceuticals.
read more
Thursday, August 28, 2025
Piramal Pharma Limited (PPL) published its fourth annual Sustainability Report for FY2025, documenting performance and progress under the theme “Innovating Responsibly. Growing Sustainably.”
read more
Thursday, January 29, 2026
Piramal Pharma Limited reported consolidated revenue from operations of ?2,140 crore for Q3 FY26, down 3% from ?2,204 crore in Q3 FY25, with 9M FY26 revenue declining 4% to ?6,117 crore from ?6,397 crore.
read more
Piramal Pharma Limited’s Pharma Solutions business, held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more